Fenwal, a global medical technology company focused on improving blood collection, separation, safety and availability, has received the US Food and Drug Administration 510(k) clearance to market its ALYX component collection system with new wireless data export capabilities.
The ALYX system is a mobile blood component collection device used primarily to collect red blood cells. The system can collect two units of red cells from a single donor in less than 30 minutes.
The addition of wireless data export allows blood collection professionals to electronically access detailed information about donation procedures on mobile and fixed-site blood drives.
The data can then be used to track and improve blood center performance and enhance the donation experience for donors and collectors.
Fenwal chief technology officer William H Cork said in providing data export for apheresis systems, their objective is to help the professionals who collect blood and plasma to improve how they work, optimizing their productivity and offering a positive experience for donors.
"Since ALYX is a mobile collection system used in many different settings outside blood centers, wireless capability is helpful to transmit information about mobile collection, allowing centers to gain new insight into their efficiency on mobile blood drives," Cork said.